APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunoprecipitation Testing

Immunoprecipitation (IP) is the small-scale affinity purification of antigens using a specific antibody that is immobilized to a solid support such as magnetic particles or agarose resin. Immunoprecipitation is one of the most widely used methods for isolation of proteins and other biomolecules from cell or tissue lysates for the purpose of subsequent detection by western blotting and other assay techniques.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Immunoprecipitation (IP) is the small-scale affinity purification of antigens using a specific antibody that is immobilized to a solid support such as magnetic particles or agarose resin. Immunoprecipitation is one of the most widely used methods for isolation of proteins and other biomolecules from cell or tissue lysates for the purpose of subsequent detection by western blotting and other assay techniques.

Selected research

Market Outlook & Growth Opportunities

Global Immunoprecipitation Testing Market Outlook and Growth Opportunities 2026

28 December 2025195 pages

Choose your research edition.

Industry ResearchImmunoprecipitation Testing Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunoprecipitation Testing Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Immunoprecipitation Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunoprecipitation Testing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunoprecipitation Testing Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Immunoprecipitation (IP) is the small-scale affinity purification of antigens using a specific antibody that is immobilized to a solid support such as magnetic particles or agarose resin. Immunoprecipitation is one of the most widely used methods for isolation of proteins and other biomolecules from cell or tissue lysates for the purpose of subsequent detection by western blotting and other assay techniques.

The classification of Immunoprecipitation Testing includes Individual Protein Immunoprecipitation, Co-Immunoprecipitation (Co-IP), Chromatin Immunoprecipitation (ChIP), RNA Immunoprecipitation (RIP) and others. The proportion of Individual Protein Immunoprecipitation in 2019 is about34%, the proportion of Co-Immunoprecipitation (Co-IP) is 26% in 2019.

Immunoprecipitation Testing is widely used in Academic & Research Institutes, Pharmaceutical Companies and Contract Research Organizations. The most proportion of Immunoprecipitation Testing is Academic & Research Institutes, and the sales proportion in 2019 is 51%.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 43% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.

Market competition is intense. Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, GenScript, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report provides an overview of the global Immunoprecipitation Testing market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immunoprecipitation Testing and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immunoprecipitation Testing sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immunoprecipitation Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

Immunoprecipitation Testing Segment by Company

Thermo Fischer Scientific

Merck

GenScript

Bio-Techne

BioLegend

Takara Bio

Abcam

Rockland Immunochemicals

Cell Signaling Technology

Geno Technology

Immunoprecipitation Testing Segment by Type

Individual Protein Immunoprecipitation

Co-Immunoprecipitation (Co-IP)

Chromatin Immunoprecipitation (ChIP)

RNA Immunoprecipitation (RIP)

Others

Immunoprecipitation Testing Segment by Application

Academic & Research Institutes

Pharmaceutical Companies

Contract Research Organizations

Immunoprecipitation Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Immunoprecipitation Testing status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Immunoprecipitation Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Immunoprecipitation Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Immunoprecipitation Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunoprecipitation Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunoprecipitation Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunoprecipitation Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immunoprecipitation Testing market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immunoprecipitation Testing industry.

Chapter 3: Detailed analysis of Immunoprecipitation Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Immunoprecipitation Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Immunoprecipitation Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Immunoprecipitation Testing Industry Trends Table 2. Immunoprecipitation Testing Industry Drivers Table 3. Immunoprecipitation Testing Industry Opportunities and Challenges Table 4. Immunoprecipitation Testing Industry Restraints Table 5. Global Immunoprecipitation Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Immunoprecipitation Testing Revenue Share by Company (2021-2026) Table 7. Global Immunoprecipitation Testing Sales Volume by Company (Units) & (2021-2026) Table 8. Global Immunoprecipitation Testing Sales Volume Share by Company (2021-2026) Table 9. Global Immunoprecipitation Testing Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Immunoprecipitation Testing Company Ranking, (2024-2026) & (USD Million) Table 11. Global Immunoprecipitation Testing Key Company Manufacturing Base & Headquarters Table 12. Global Immunoprecipitation Testing Company, Product Type & Application Table 13. Global Immunoprecipitation Testing Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Immunoprecipitation Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Individual Protein Immunoprecipitation Table 18. Significant Companies of Co-Immunoprecipitation (Co-IP) Table 19. Significant Companies of Chromatin Immunoprecipitation (ChIP) Table 20. Significant Companies of RNA Immunoprecipitation (RIP) Table 21. Significant Companies of Others Table 22. Global Immunoprecipitation Testing Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 23. Global Immunoprecipitation Testing Sales Volume by Type (2021-2026) & (Units) Table 24. Global Immunoprecipitation Testing Sales Volume by Type (2027-2032) & (Units) Table 25. Global Immunoprecipitation Testing Sales Volume Share by Type (2021-2026) Table 26. Global Immunoprecipitation Testing Sales Volume Share by Type (2027-2032) Table 27. Global Immunoprecipitation Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Immunoprecipitation Testing Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Immunoprecipitation Testing Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Immunoprecipitation Testing Sales Value Share by Type (2021-2026) Table 31. Global Immunoprecipitation Testing Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Academic & Research Institutes Table 33. Significant Companies of Pharmaceutical Companies Table 34. Significant Companies of Contract Research Organizations Table 35. Global Immunoprecipitation Testing Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 36. Global Immunoprecipitation Testing Sales Volume by Application (2021-2026) & (Units) Table 37. Global Immunoprecipitation Testing Sales Volume by Application (2027-2032) & (Units) Table 38. Global Immunoprecipitation Testing Sales Volume Share by Application (2021-2026) Table 39. Global Immunoprecipitation Testing Sales Volume Share by Application (2027-2032) Table 40. Global Immunoprecipitation Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Immunoprecipitation Testing Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Immunoprecipitation Testing Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Immunoprecipitation Testing Sales Value Share by Application (2021-2026) Table 44. Global Immunoprecipitation Testing Sales Value Share by Application (2027-2032) Table 45. Global Immunoprecipitation Testing Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 46. Global Immunoprecipitation Testing Sales by Region (2021-2026) & (Units) Table 47. Global Immunoprecipitation Testing Sales Market Share by Region (2021-2026) Table 48. Global Immunoprecipitation Testing Sales by Region (2027-2032) & (Units) Table 49. Global Immunoprecipitation Testing Sales Market Share by Region (2027-2032) Table 50. Global Immunoprecipitation Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Immunoprecipitation Testing Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Immunoprecipitation Testing Sales Value Share by Region (2021-2026) Table 53. Global Immunoprecipitation Testing Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Immunoprecipitation Testing Sales Value Share by Region (2027-2032) Table 55. Global Immunoprecipitation Testing Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Immunoprecipitation Testing Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Immunoprecipitation Testing Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 58. Global Immunoprecipitation Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Immunoprecipitation Testing Sales by Country (2021-2026) & (Units) Table 60. Global Immunoprecipitation Testing Sales Market Share by Country (2021-2026) Table 61. Global Immunoprecipitation Testing Sales by Country (2027-2032) & (Units) Table 62. Global Immunoprecipitation Testing Sales Market Share by Country (2027-2032) Table 63. Global Immunoprecipitation Testing Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Immunoprecipitation Testing Sales Value Market Share by Country (2021-2026) Table 65. Global Immunoprecipitation Testing Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Immunoprecipitation Testing Sales Value Market Share by Country (2027-2032) Table 67. Thermo Fischer Scientific Company Information Table 68. Thermo Fischer Scientific Business Overview Table 69. Thermo Fischer Scientific Immunoprecipitation Testing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Thermo Fischer Scientific Immunoprecipitation Testing Product Portfolio Table 71. Thermo Fischer Scientific Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Immunoprecipitation Testing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Merck Immunoprecipitation Testing Product Portfolio Table 76. Merck Recent Development Table 77. GenScript Company Information Table 78. GenScript Business Overview Table 79. GenScript Immunoprecipitation Testing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. GenScript Immunoprecipitation Testing Product Portfolio Table 81. GenScript Recent Development Table 82. Bio-Techne Company Information Table 83. Bio-Techne Business Overview Table 84. Bio-Techne Immunoprecipitation Testing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Bio-Techne Immunoprecipitation Testing Product Portfolio Table 86. Bio-Techne Recent Development Table 87. BioLegend Company Information Table 88. BioLegend Business Overview Table 89. BioLegend Immunoprecipitation Testing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. BioLegend Immunoprecipitation Testing Product Portfolio Table 91. BioLegend Recent Development Table 92. Takara Bio Company Information Table 93. Takara Bio Business Overview Table 94. Takara Bio Immunoprecipitation Testing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Takara Bio Immunoprecipitation Testing Product Portfolio Table 96. Takara Bio Recent Development Table 97. Abcam Company Information Table 98. Abcam Business Overview Table 99. Abcam Immunoprecipitation Testing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Abcam Immunoprecipitation Testing Product Portfolio Table 101. Abcam Recent Development Table 102. Rockland Immunochemicals Company Information Table 103. Rockland Immunochemicals Business Overview Table 104. Rockland Immunochemicals Immunoprecipitation Testing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Rockland Immunochemicals Immunoprecipitation Testing Product Portfolio Table 106. Rockland Immunochemicals Recent Development Table 107. Cell Signaling Technology Company Information Table 108. Cell Signaling Technology Business Overview Table 109. Cell Signaling Technology Immunoprecipitation Testing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Cell Signaling Technology Immunoprecipitation Testing Product Portfolio Table 111. Cell Signaling Technology Recent Development Table 112. Geno Technology Company Information Table 113. Geno Technology Business Overview Table 114. Geno Technology Immunoprecipitation Testing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Geno Technology Immunoprecipitation Testing Product Portfolio Table 116. Geno Technology Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Immunoprecipitation Testing Distributors List Table 120. Immunoprecipitation Testing Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Immunoprecipitation Testing Product Image Figure 2. Global Immunoprecipitation Testing Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunoprecipitation Testing Sales Value (2021-2032) & (US$ Million) Figure 4. Global Immunoprecipitation Testing Sales (2021-2032) & (Units) Figure 5. Global Immunoprecipitation Testing Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Immunoprecipitation Testing Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Individual Protein Immunoprecipitation Image Figure 10. Co-Immunoprecipitation (Co-IP) Image Figure 11. Chromatin Immunoprecipitation (ChIP) Image Figure 12. RNA Immunoprecipitation (RIP) Image Figure 13. Others Image Figure 14. Global Immunoprecipitation Testing Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 15. Global Immunoprecipitation Testing Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Immunoprecipitation Testing Sales Volume Share by Type (2021-2032) Figure 17. Global Immunoprecipitation Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Immunoprecipitation Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Immunoprecipitation Testing Sales Value Share by Type (2021-2032) Figure 20. Academic & Research Institutes Image Figure 21. Pharmaceutical Companies Image Figure 22. Contract Research Organizations Image Figure 23. Global Immunoprecipitation Testing Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global Immunoprecipitation Testing Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Immunoprecipitation Testing Sales Volume Share by Application (2021-2032) Figure 26. Global Immunoprecipitation Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Immunoprecipitation Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Immunoprecipitation Testing Sales Value Share by Application (2021-2032) Figure 29. Global Immunoprecipitation Testing Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 30. Global Immunoprecipitation Testing Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Immunoprecipitation Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Immunoprecipitation Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Immunoprecipitation Testing Sales Value (2021-2032) & (US$ Million) Figure 34. North America Immunoprecipitation Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Immunoprecipitation Testing Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Immunoprecipitation Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Immunoprecipitation Testing Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Immunoprecipitation Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Immunoprecipitation Testing Sales Value (2021-2032) & (US$ Million) Figure 40. South America Immunoprecipitation Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Immunoprecipitation Testing Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Immunoprecipitation Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Immunoprecipitation Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Immunoprecipitation Testing Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Immunoprecipitation Testing Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Individual Protein Immunoprecipitation
  • Co-Immunoprecipitation (Co-IP)
  • Chromatin Immunoprecipitation (ChIP)
  • RNA Immunoprecipitation (RIP)
  • Others
Applications
  • Academic & Research Institutes
  • Pharmaceutical Companies
  • Contract Research Organizations
Companies covered
  • Thermo Fischer Scientific
  • Merck
  • GenScript
  • Bio-Techne
  • BioLegend
  • Takara Bio
  • Abcam
  • Rockland Immunochemicals
  • Cell Signaling Technology
  • Geno Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immunoprecipitation Testing Sales Value (2021-2032)
  4. 1.2.2 Global Immunoprecipitation Testing Sales Volume (2021-2032)
  5. 1.2.3 Global Immunoprecipitation Testing Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Immunoprecipitation Testing Market Dynamics
  1. 2.1 Immunoprecipitation Testing Industry Trends
  2. 2.2 Immunoprecipitation Testing Industry Drivers
  3. 2.3 Immunoprecipitation Testing Industry Opportunities and Challenges
  4. 2.4 Immunoprecipitation Testing Industry Restraints
3 Immunoprecipitation Testing Market by Company
  1. 3.1 Global Immunoprecipitation Testing Company Revenue Ranking in 2025
  2. 3.2 Global Immunoprecipitation Testing Revenue by Company (2021-2026)
  3. 3.3 Global Immunoprecipitation Testing Sales Volume by Company (2021-2026)
  4. 3.4 Global Immunoprecipitation Testing Average Price by Company (2021-2026)
  5. 3.5 Global Immunoprecipitation Testing Company Ranking (2024-2026)
  6. 3.6 Global Immunoprecipitation Testing Company Manufacturing Base and Headquarters
  7. 3.7 Global Immunoprecipitation Testing Company Product Type and Application
  8. 3.8 Global Immunoprecipitation Testing Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Immunoprecipitation Testing Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Immunoprecipitation Testing Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Immunoprecipitation Testing Market by Type
  1. 4.1 Immunoprecipitation Testing Type Introduction
  2. 4.1.1 Individual Protein Immunoprecipitation
  3. 4.1.2 Co-Immunoprecipitation (Co-IP)
  4. 4.1.3 Chromatin Immunoprecipitation (ChIP)
  5. 4.1.4 RNA Immunoprecipitation (RIP)
  6. 4.1.5 Others
  7. 4.2 Global Immunoprecipitation Testing Sales Volume by Type
  8. 4.2.1 Global Immunoprecipitation Testing Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Immunoprecipitation Testing Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Immunoprecipitation Testing Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Immunoprecipitation Testing Sales Value by Type
  12. 4.3.1 Global Immunoprecipitation Testing Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Immunoprecipitation Testing Sales Value by Type (2021-2032)
  14. 4.3.3 Global Immunoprecipitation Testing Sales Value Share by Type (2021-2032)
5 Immunoprecipitation Testing Market by Application
  1. 5.1 Immunoprecipitation Testing Application Introduction
  2. 5.1.1 Academic & Research Institutes
  3. 5.1.2 Pharmaceutical Companies
  4. 5.1.3 Contract Research Organizations
  5. 5.2 Global Immunoprecipitation Testing Sales Volume by Application
  6. 5.2.1 Global Immunoprecipitation Testing Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Immunoprecipitation Testing Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Immunoprecipitation Testing Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Immunoprecipitation Testing Sales Value by Application
  10. 5.3.1 Global Immunoprecipitation Testing Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Immunoprecipitation Testing Sales Value by Application (2021-2032)
  12. 5.3.3 Global Immunoprecipitation Testing Sales Value Share by Application (2021-2032)
6 Immunoprecipitation Testing Regional Sales and Value Analysis
  1. 6.1 Global Immunoprecipitation Testing Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immunoprecipitation Testing Sales by Region (2021-2032)
  3. 6.2.1 Global Immunoprecipitation Testing Sales by Region: 2021-2026
  4. 6.2.2 Global Immunoprecipitation Testing Sales by Region (2027-2032)
  5. 6.3 Global Immunoprecipitation Testing Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Immunoprecipitation Testing Sales Value by Region (2021-2032)
  7. 6.4.1 Global Immunoprecipitation Testing Sales Value by Region: 2021-2026
  8. 6.4.2 Global Immunoprecipitation Testing Sales Value by Region (2027-2032)
  9. 6.5 Global Immunoprecipitation Testing Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Immunoprecipitation Testing Sales Value (2021-2032)
  12. 6.6.2 North America Immunoprecipitation Testing Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Immunoprecipitation Testing Sales Value (2021-2032)
  15. 6.7.2 Europe Immunoprecipitation Testing Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Immunoprecipitation Testing Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Immunoprecipitation Testing Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Immunoprecipitation Testing Sales Value (2021-2032)
  21. 6.9.2 South America Immunoprecipitation Testing Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Immunoprecipitation Testing Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Immunoprecipitation Testing Sales Value Share by Country, 2025 VS 2032
7 Immunoprecipitation Testing Country-level Sales and Value Analysis
  1. 7.1 Global Immunoprecipitation Testing Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Immunoprecipitation Testing Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Immunoprecipitation Testing Sales by Country (2021-2032)
  4. 7.3.1 Global Immunoprecipitation Testing Sales by Country (2021-2026)
  5. 7.3.2 Global Immunoprecipitation Testing Sales by Country (2027-2032)
  6. 7.4 Global Immunoprecipitation Testing Sales Value by Country (2021-2032)
  7. 7.4.1 Global Immunoprecipitation Testing Sales Value by Country (2021-2026)
  8. 7.4.2 Global Immunoprecipitation Testing Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Immunoprecipitation Testing Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Immunoprecipitation Testing Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Immunoprecipitation Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fischer Scientific
  2. 8.1.1 Thermo Fischer Scientific Company Information
  3. 8.1.2 Thermo Fischer Scientific Business Overview
  4. 8.1.3 Thermo Fischer Scientific Immunoprecipitation Testing Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fischer Scientific Immunoprecipitation Testing Product Portfolio
  6. 8.1.5 Thermo Fischer Scientific Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Immunoprecipitation Testing Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Immunoprecipitation Testing Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 GenScript
  14. 8.3.1 GenScript Company Information
  15. 8.3.2 GenScript Business Overview
  16. 8.3.3 GenScript Immunoprecipitation Testing Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GenScript Immunoprecipitation Testing Product Portfolio
  18. 8.3.5 GenScript Recent Developments
  19. 8.4 Bio-Techne
  20. 8.4.1 Bio-Techne Company Information
  21. 8.4.2 Bio-Techne Business Overview
  22. 8.4.3 Bio-Techne Immunoprecipitation Testing Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bio-Techne Immunoprecipitation Testing Product Portfolio
  24. 8.4.5 Bio-Techne Recent Developments
  25. 8.5 BioLegend
  26. 8.5.1 BioLegend Company Information
  27. 8.5.2 BioLegend Business Overview
  28. 8.5.3 BioLegend Immunoprecipitation Testing Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BioLegend Immunoprecipitation Testing Product Portfolio
  30. 8.5.5 BioLegend Recent Developments
  31. 8.6 Takara Bio
  32. 8.6.1 Takara Bio Company Information
  33. 8.6.2 Takara Bio Business Overview
  34. 8.6.3 Takara Bio Immunoprecipitation Testing Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Takara Bio Immunoprecipitation Testing Product Portfolio
  36. 8.6.5 Takara Bio Recent Developments
  37. 8.7 Abcam
  38. 8.7.1 Abcam Company Information
  39. 8.7.2 Abcam Business Overview
  40. 8.7.3 Abcam Immunoprecipitation Testing Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Abcam Immunoprecipitation Testing Product Portfolio
  42. 8.7.5 Abcam Recent Developments
  43. 8.8 Rockland Immunochemicals
  44. 8.8.1 Rockland Immunochemicals Company Information
  45. 8.8.2 Rockland Immunochemicals Business Overview
  46. 8.8.3 Rockland Immunochemicals Immunoprecipitation Testing Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Rockland Immunochemicals Immunoprecipitation Testing Product Portfolio
  48. 8.8.5 Rockland Immunochemicals Recent Developments
  49. 8.9 Cell Signaling Technology
  50. 8.9.1 Cell Signaling Technology Company Information
  51. 8.9.2 Cell Signaling Technology Business Overview
  52. 8.9.3 Cell Signaling Technology Immunoprecipitation Testing Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cell Signaling Technology Immunoprecipitation Testing Product Portfolio
  54. 8.9.5 Cell Signaling Technology Recent Developments
  55. 8.10 Geno Technology
  56. 8.10.1 Geno Technology Company Information
  57. 8.10.2 Geno Technology Business Overview
  58. 8.10.3 Geno Technology Immunoprecipitation Testing Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Geno Technology Immunoprecipitation Testing Product Portfolio
  60. 8.10.5 Geno Technology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immunoprecipitation Testing Value Chain Analysis
  2. 9.1.1 Immunoprecipitation Testing Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immunoprecipitation Testing Sales Mode & Process
  6. 9.2 Immunoprecipitation Testing Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immunoprecipitation Testing Distributors
  9. 9.2.3 Immunoprecipitation Testing Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst